Literature DB >> 8489103

Perforated gastric and duodenal ulcer: an analysis of prognostic factors.

L S Hamby1, T N Zweng, W E Strodel.   

Abstract

A review of patients treated operatively for perforated ulcer was undertaken to determine factors that independently predict mortality and morbidity. From 1980 to 1989 84 patients were treated with operative mortality and morbidity rates of 18 and 37 per cent, respectively. Patients with gastric ulcer were significantly older and were more likely to have concomitant medical problems, to use steroids, and be hospitalized at time of their perforation. They also had a higher perioperative mortality rate when compared to patients with gastroduodenal ulcers (P < 0.05 for each). Patients treated with definitive operation (n = 51) had a significantly lower recurrent ulcer rate when compared to an equivalent group treated with simple closure (n = 33) (mean follow-up, 47 months). Multivariate analysis confirmed a patient's likelihood of complication or death could be predicted using three variables (P < 0.03); age greater than 42 years, hospitalization at time of perforation, concomitant medical illness. While the relative distribution of these three factors in patients with gastric versus peptic ulcers appears to account for the difference in outcome between these two groups, the distribution of these factors between patients treated with patch closure and definitive operation was not significantly different. Patient outcome from operation for perforated ulcer is dependent on preoperative conditions and appears to be independent of surgical procedure performed. There was no benefit to simple closure of a perforated ulcer. Definitive procedures of perforated ulcers are associated with lower ulcer recurrence and therefore are advocated to treat perforation.

Entities:  

Mesh:

Year:  1993        PMID: 8489103

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  8 in total

1.  Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer.

Authors:  Mario Testini; Piero Portincasa; Giuseppe Piccinni; Germana Lissidini; Fabio Pellegrini; Luigi Greco
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

2.  Perforated peptic ulcer treated by simple closure and Helicobacter pylori eradication.

Authors:  Juan C Rodríguez-Sanjuán; Roberto Fernández-Santiago; Rosa A García; Soledad Trugeda; Isabel Seco; Fernando la de Torre; Angel Naranjo; Manuel Gómez-Fleitas
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

3.  Cost-effectiveness of strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease.

Authors:  C W Ko; R A Deyo
Journal:  J Gen Intern Med       Date:  2000-06       Impact factor: 5.128

4.  Influence of age, comorbidity, type of operation and other variables on lethality and duration of post-operative hospital stay in patients with peptic ulcer. An analysis of 303 surgically treated patients.

Authors:  J Högel; R J Rieker; R Eisele; E Schmid
Journal:  Langenbecks Arch Chir       Date:  1996

5.  Comparison and validation of scoring systems in a cohort of patients treated for perforated peptic ulcer.

Authors:  Mahmut Koç; Omer Yoldaş; Yusuf Alper Kiliç; Erdal Göçmen; Tamer Ertan; Hayrettin Dizen; Mesut Tez
Journal:  Langenbecks Arch Surg       Date:  2007-02-14       Impact factor: 3.445

6.  Generalized peritonitis requiring re-operation after leakage of omental patch repair of perforated peptic ulcer.

Authors:  Hemmat Maghsoudi; Alireza Ghaffari
Journal:  Saudi J Gastroenterol       Date:  2011 Mar-Apr       Impact factor: 2.485

7.  A prospective cohort study of postoperative complications in the management of perforated peptic ulcer.

Authors:  Smita S Sharma; Manju R Mamtani; Mamta S Sharma; Hemant Kulkarni
Journal:  BMC Surg       Date:  2006-06-16       Impact factor: 2.102

8.  Incidence and short-term mortality from perforated peptic ulcer in Korea: a population-based study.

Authors:  Seungjin Bae; Ki-Nam Shim; Nayoung Kim; Jung Mook Kang; Dong-Sook Kim; Kyoung-Min Kim; Yu Kyung Cho; Sung Woo Jung
Journal:  J Epidemiol       Date:  2012-09-01       Impact factor: 3.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.